Company intelligence / Profile preview
Laurus Labs
Hyderabad, Telangana, Indialauruslabs.com ↗
- Ownership
- Private
- Employees
- ~6000
- Development stage
- Other
01
Overview
Laurus Labs has established itself as a global leader in the manufacture of APIs—especially antiretrovirals—and generic formulations. The company has expanded into biotechnology with capabilities in precision fermentation and cell/gene therapies. Its commercial portfolio includes ARV APIs/formulations supplied globally; it also supports clinical trials through its CDMO business. Recent investments have positioned it at the forefront of India’s cell/gene therapy sector with products like NexCAR19 CAR-T cell therapy entering clinical trials for blood cancers.
- Therapeutic areas
- Infectious DiseasesHematologyEndocrinologyOncologyCardiovascular
- Modalities
- Small moleculeBiologicRecombinant proteinCell therapyGene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ImmunoACTIIT Kanpur
Beyond the preview
Go deeper on Laurus Labs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laurus Labs.